Calendar Replimune Group, Inc.

Equities

REPL

US76029N1063

Market Closed - Nasdaq 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
8.17 USD -0.97% Intraday chart for Replimune Group, Inc. -0.37% -3.08%

Chart calendar Replimune Group, Inc.

3d1.IjVjDTpLp3OBIv1ZMznUw8ov4NWxZNmrdPt30uc-IbU.SAVSO1wT9DDbYZogBXWSgphgl7TnMojoBLg4_5IKRsJkRBJOQwPCGdRUzQ~2f923d423b5a6600a92212ca3dd2b69c

Upcoming events on Replimune Group, Inc.

2024-04-07 01:00 pm American Association for Cancer Research Meeting - Abstract No - 9269
2024-04-08 09:00 am American Association for Cancer Research Meeting - Abstract No - 2467
2024-05-15 Q4 2024 Earnings Release (Projected)
2024-07-31 Q1 2025 Earnings Release (Projected)
2024-10-30 Q2 2025 Earnings Release (Projected)
2025-02-05 Q3 2025 Earnings Release (Projected)

Past events on Replimune Group, Inc.

2024-03-14 10:45 am Barclays Global Healthcare Conference - Fireside Chat
2024-03-12 Jefferies Biotech on the Bay Summit
2024-03-12 02:20 pm Leerink Partners Global Biopharma Conference - Fireside Chat
2024-02-08 08:00 am Q3 2024 Earnings Release
2024-01-08 02:15 pm JPMorgan Healthcare Conference
2023-12-05 08:00 am Business Update Call
2023-11-07 08:00 am Q2 2024 Earnings Release
2023-09-06 03:00 pm Annual General Meeting
2023-08-08 Wedbush PacGrow Healthcare Conference
2023-08-08 01:30 pm BTIG Biotechnology Conference
2023-08-03 08:00 am Q1 2024 Earnings Release
2023-06-08 01:00 pm Jefferies Global Healthcare Conference
2023-06-05 02:15 pm American Society of Clinical Oncology Conference - Abstract Number: TPS6106
2023-06-05 09:00 am American Society of Clinical Oncology Conference - Abstract Number: TPS4178
2023-06-05 09:00 am American Society of Clinical Oncology Conference - Abstract Number: TPS3628
2023-06-03 02:15 pm American Society of Clinical Oncology Conference - Abstract Number: 9509
2023-06-03 02:15 pm American Society of Clinical Oncology Conference - Abstract Number: 9527
2023-05-18 08:00 am Q4 2023 Earnings Release
2023-05-16 Piper Sandler Spring Biopharma Symposium
2023-03-15 Jefferies Biotech on the Bay Summit

Annual results

Fiscal PeriodMarch 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
-30,8
-35,1
12.15%
0,00
0,00
-
0,00
0,00
-
-116
-118
1.95%
-175
-176
0.78%

0,00

EBIT
Million USD
Released
Forecast
Spread
-30,9
-41,0
24.53%
-56,2
-57,1
1.55%
-80,0
-78,4
-2.01%
-118
-118
-0.69%
-177
-169
-4.69%

-227

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-30,8
-41,5
25.71%
-52,6
-53,2
1.12%
-80,9
-79,6
-1.54%
-118
-117
-0.82%
-174
-169
-2.66%

-212

Net income
Million USD
Released
Forecast
Spread
-30,8
-41,4
25.54%
-52,6
-53,2
1.06%
-80,9
-79,6
-1.6%
-118
-117
-0.83%
-174
-169
-2.85%

-213

EPS
USD
Released
Forecast
Spread
-1,33
-1,51
11.9%
-1,54
-1,57
2%
-1,75
-1,76
0.43%
-2,26
-2,28
0.72%
-2,99
-2,91
-2.78%

-3,17

Announcement Date28/06/1903/06/2020/05/2119/05/2218/05/23-

Quarterly results

Fiscal PeriodMarch 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-29,7
-29,8
0.45%
-32,0
-31,2
-2.44%
-40,9
-33,4
-22.55%
-41,6
-42,6
2.35%
-41,6
-43,2
3.61%
-53,0
-44,0
-20.57%
-55,6
-54,1
-2.8%
-63,8
-57,1
-11.84%
-56,5
-64,3
12.11%

-56,1


-57,9


-58,8


-60,1


-61,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-29,7
-29,4
-0.88%
-31,7
-30,7
-3.39%
-42,3
-32,9
-28.58%
-43,1
-42,1
-2.47%
-39,7
-42,7
7.11%
-49,0
-42,2
-15.9%
-49,4
-51,8
4.69%
-60,2
-55,8
-7.98%
-50,6
-60,6
16.43%

-52,9


-54,8


-56,1


-56,8


-58,5

Net income
Million USD
Released
Forecast
Spread
-29,7
-29,4
-0.88%
-31,7
-30,7
-3.37%
-42,3
-32,9
-28.5%
-43,1
-42,0
-2.54%
-39,7
-42,8
7.32%
-49,2
-43,1
-14.28%
-49,6
-51,8
4.3%
-60,0
-54,6
-9.97%
-51,1
-61,7
17.11%

-53,6


-54,4


-54,4


-54,1


-54,4

EPS
USD
Released
Forecast
Spread
-0,57
-0,58
1.33%
-0,60
-0,60
-0.66%
-0,78
-0,63
-24.06%
-0,79
-0,78
-0.99%
-0,69
-0,77
10.39%
-0,74
-0,69
-7.59%
-0,75
-0,84
10.84%
-0,90
-0,86
-4.48%
-0,77
-0,94
17.77%

-0,80


-0,80


-0,78


-0,79


-0,80

Announcement Date03/02/2219/05/2204/08/2203/11/2209/02/2318/05/2303/08/2307/11/2308/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise